CLARK ESTATES INC/NY

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1056466 NEW YORK, NY

Position in CPRX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

+$0 QoQ

Shares Held

113,918

0.0% QoQ

Ownership

0.093%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CLARK ESTATES INC/NY holds $19,231,309 across 5 Biotechnology names. CPRX ranks #5 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	STTK	Shattuck Labs, Inc.	1,430,167	$9,925,358
2	HALO	Halozyme Therapeutics, Inc.	44,868	$3,511,818
3	HRMY	Harmony Biosciences Holdings, Inc.	81,300	$2,960,133
4	INCY	Incyte Corp	25,000	$2,834,000
5	CPRX	Catalyst Pharmaceuticals, Inc. This page	113,918	$0

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	113,918	0.0%	Shares	Sole	2026-08-05
2026-03-31	—	113,918	0.0%	Shares	Sole	2026-05-11
2025-12-31	—	113,918	0.0%	Shares	Sole	2026-02-12
2025-09-30	—	113,918	0.0%	Shares	Sole	2025-11-10
2025-06-30	—	113,918	-15.3%	Shares	Sole	2025-08-11
2025-03-31	—	134,418	-27.6%	Shares	Sole	2025-05-08
2024-12-31	—	185,743	-10.8%	Shares	Sole	2025-02-06
2024-09-30	—	208,250	-7.4%	Shares	Sole	2024-11-13
2024-06-30	—	224,950	-2.6%	Shares	Sole	2024-08-08
2024-03-31	—	231,000	+17.0%	Shares	Sole	2024-05-07
2023-12-31	—	197,500	+5.1%	Shares	Sole	2024-02-12
2023-09-30	—	188,000	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.